Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · second_quarter · Q2
NIH funding Global health funding CDC funding
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Jeanette Acosta Invest in Women’s Health Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation P.L.109-417 PAHPA Opioids
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Veterans Benefits and Transition Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Opioid Crisis Response Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Opioid Crisis Response Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
American Health Care Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
American Health Care Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Healthy Relationships Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2028, Continuing Resolution NIH Funding Global Health Funding
Healthy Relationships Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2028, Continuing Resolution NIH Funding Global Health Funding
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
Further Continuing and Security Assistance Appropriations Act, 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
NIH Funding H.R.2028, Continuing Resolution
Further Continuing and Security Assistance Appropriations Act, 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
NIH Funding H.R.2028, Continuing Resolution
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Consolidated Appropriations Act, 2016
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 2029, Consolidated Appropriations Act, 2016, NIH Funding
Strengthening Public Health Emergency Response Act of 2016
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Provider Payment Sunshine Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act, related to device tax
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act, related to device tax
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Medicare Safe Needle Disposal Coverage Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Medicare Safe Needle Disposal Coverage Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act, related to device tax Corporate tax issues
Protect Medical Innovation Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Protect Medical Innovation Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Protect Medical Innovation Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 Corporate tax issues
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Pharmaceutical Quality, Security, and Accountability Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests
Pharmaceutical Quality, Security, and Accountability Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests Healthcare policy and medical technology issues Issues relating to injection safety for patients and healthcare workers
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH funding H.J. Res. 117, Continuing Appropriations Resolution, 2013, regarding FDA funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH Funding PL 112-025, Budget Control Act of 2011, related to NIH Funding
MODDERN Cures Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3497, MODDERN Cures Act of 2011
Health Care Cost Reduction Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
Health Care Cost Reduction Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act of 2011 Corporate tax issues
Health Care Cost Reduction Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.436, Protect Medical Innovation Act of 2011 Corporate tax issues
Food and Drug Administration Reform Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.3187, Food and Drug Administration Safety and Innovation Act, MDUFA and drug shortage H.R.5651, Food and Drug Administration Reform Act of 2012, MDUFA
Manufacturing American Innovation Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
Health Care Innovation and Marketplace Technologies Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.6626, Health Care Innovation and Marketplace Technologies Act of 2012 Sunshine Act
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · first_quarter · Q1
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to Veterans Affairs procurement of medical devices Issues related to medical device sterilization Issues related to hazardous drug safety Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices
NIH funding Global health funding CDC funding
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · fourth_quarter · Q4
China tariffs
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · third_quarter · Q3
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Global health funding NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · second_quarter · Q2
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · first_quarter · Q1
Issues related to antimicrobial resistance H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation P.L.109-417 PAHPA Opioids
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
NIH funding Global health funding CDC funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · fourth_quarter · Q4
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · third_quarter · Q3
NIH Funding Global Health Funding
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · first_quarter · 1A
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
H.R.2028, Continuing Resolution NIH Funding Global Health Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · second_quarter · Q2
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety
NIH Funding Global Health Funding
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · first_quarter · Q1
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
H.R.2028, Continuing Resolution NIH Funding Global Health Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · 4A
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
NIH Funding H.R.2028, Continuing Resolution
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · third_quarter · 3A
NIH Funding Global Health Funding
Diagnostics reimbursement Issues related to UDI on Medicare claim forms
Issues related to medical device tax Issues related to corporate tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · 2A
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
NIH Funding Global Health Funding
Diagnostics reimbursement Issues related to UDI on medical claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · Q4
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
NIH Funding H.R.2028, Continuing Resolution
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · third_quarter · Q3
Issues related to diagnostic regulation Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Issues related to medical device tax Issues related to corporate tax
Diagnostics reimbursement Issues related to UDI on Medicare claim forms
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · Q2
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
NIH Funding Global Health Funding
Diagnostics reimbursement Issues related to UDI on medical claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · first_quarter · Q1
NIH Funding Global Health Funding Appropriations Budget
Issues related to diagnostic regulation Bio-specimen regulatory issue Issues related to drug shortages Issues related to pandemic preparedness Issues related to Health IT
Diagnostics reimbursement Issues related to UDI on medical claim forms Issues related to patient safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · fourth_quarter · Q4
Diagnostics reimbursement Issues related to UDI on medical claim forms
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Issues related to Trans-Pacific Partnership (TPP)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · third_quarter · Q3
Issues related to Sharps disposal reimbursement Diagnostics reimbursement Issues related to UDI on medical claim forms
NIH Funding
Issues related to diagnostic regulation Issues related to drug shortages Issues related to pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · 2A
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to SGR Issues related to Sharps disposal Clinical lab fee schedule reform
NIH Funding PEPFAR Funding
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · 1A
NIH Funding BARDA Funding
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · Q2
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to SGR Issues related to Sharps disposal Clinical lab fee schedule reform
NIH Funding PEPFAR Funding
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · Q1
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
NIH Funding BARDA Funding
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · fourth_quarter · 4A
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Issues related to device payment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · third_quarter · 3A
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · second_quarter · 2A
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · first_quarter · 1A
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
H.R. 436, Protect Medical Innovation Act, related to device tax
Issues related to safe handling of hazardous drugs Healthcare policy issues Issues related to FDA regulation of generic drugs Issues related to HIT Healthcare-associated infections (HAIs) Issues related to diagnostic regulation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · fourth_quarter · Q4
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Issues related to device payment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · third_quarter · Q3
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · second_quarter · Q2
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · first_quarter · Q1
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
Issues related to safe handling of hazardous drugs Healthcare policy issues Issues related to FDA regulation of generic drugs Issues related to HIT Healthcare-associated infections (HAIs) Issues related to diagnostic regulation
H.R. 436, Protect Medical Innovation Act, related to device tax
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · fourth_quarter · Q4
FDA regulation of diagnostic tests Healthcare-associated infections (HAIs) Healthcare policy and medical technology/device issues
H.R. 436, Protect Medical Innovation Act, related to device tax Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · third_quarter · Q3
Reimbursement for diagnostic tests
NIH Funding FDA Funding PEPFAR Funding
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · second_quarter · Q2
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests Healthcare policy and medical technology issues Issues relating to injection safety for patients and healthcare workers
NIH Funding FDA Funding PEPFAR
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · first_quarter · Q1
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
NIH Funding FDA Funding PEPFAR
Healthcare policy and medical technology issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · fourth_quarter · Q4
H.R.6626, Health Care Innovation and Marketplace Technologies Act of 2012 Sunshine Act
H.R. 436, Protect Medical Innovation Act of 2011 Corporate tax issues
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH funding H.J. Res. 117, Continuing Appropriations Resolution, 2013, regarding FDA funding
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · third_quarter · Q3
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH Funding PL 112-025, Budget Control Act of 2011, related to NIH Funding
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
Healthcare policy issues
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · second_quarter · Q2
S.3187, Food and Drug Administration Safety and Innovation Act, MDUFA and drug shortage H.R.5651, Food and Drug Administration Reform Act of 2012, MDUFA
H.R.436, Protect Medical Innovation Act of 2011 Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Issues related to diagnostic regulation Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIH Funding Global Health Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
H.R. 2029, Consolidated Appropriations Act, 2016, NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.523, Protect Medical Innovation Act of 2013 Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Understand purpose of Brazil Caucus
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3497, MODDERN Cures Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE